NEW BRUNSWICK, N.J., April 24, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical businesses for the investment community beginning at 8:30 a.m. (Eastern Time) on Wednesday, May 17, 2017 at the Hyatt Regency Hotel in New Brunswick, New Jersey, and ending at approximately 2:30 p.m.
Alex Gorsky, Chairman and Chief Executive Officer, will provide opening remarks. Highlights of the day will include speakers from Johnson & Johnson's Executive and Management Committee as well as leaders from the therapeutic areas within the Pharmaceutical Research and Development organization.
The agenda for the day will be posted on the Investor Relations website on approximately May 10th.
Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations.
A replay and podcast will be available shortly after the live webcast.
SOURCE Johnson & Johnson
Press Contacts: Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M); Amy Jo Meyer, (732) 524-6678, (908) 616-6250 (M); Investor Contacts: Joseph J. Wolk, (732) 524-1142; Lesley Fishman, (732) 524-3922